These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11796385)

  • 21. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.
    Zeitlinger MA; Dehghanyar P; Mayer BX; Schenk BS; Neckel U; Heinz G; Georgopoulos A; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3548-53. PubMed ID: 14576116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS; Hall RG
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Jevons G; Brenwald NP; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Oct; 40(4):573-7. PubMed ID: 9372428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration.
    Healy DP; Holland EJ; Nordlund ML; Dunn S; Chow C; Lindstrom RL; Hardten D; Davis E
    Cornea; 2004 Apr; 23(3):255-63. PubMed ID: 15084858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.
    Boselli E; Breilh D; Rimmelé T; Djabarouti S; Saux MC; Chassard D; Allaouchiche B
    Crit Care Med; 2005 Jan; 33(1):104-9. PubMed ID: 15644655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
    Frei CR; Burgess DS
    Pharmacotherapy; 2005 Sep; 25(9):1161-7. PubMed ID: 16164390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model.
    Motos A; Kuti JL; Li Bassi G; Torres A; Nicolau DP
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery.
    von Baum H; Böttcher S; Hoffmann H; Sonntag HG
    J Antimicrob Chemother; 2001 May; 47(5):729-30. PubMed ID: 11328803
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.
    Hutschala D; Skhirtladze K; Zuckermann A; Wisser W; Jaksch P; Mayer-Helm BX; Burgmann H; Wolner E; Müller M; Tschernko EM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5107-11. PubMed ID: 16304179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
    Al-Shaer MH; Alghamdi WA; Alsultan A; An G; Ahmed S; Alkabab Y; Banu S; Barbakadze K; Houpt E; Kipiani M; Mikiashvili L; Cegielski JP; Kempker RR; Heysell SK; Peloquin CA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
    Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs.
    Goutelle S; Bourguignon L; Maire PH; Van Guilder M; Conte JE; Jelliffe RW
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2974-81. PubMed ID: 19380594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.
    Villani P; Viale P; Signorini L; Cadeo B; Marchetti F; Villani A; Fiocchi C; Regazzi MB; Carosi G
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2160-2. PubMed ID: 11408245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of levofloxacin into human aqueous humor.
    Kobayakawa S; Tochikubo T; Tsuji A
    Ophthalmic Res; 2003; 35(2):97-101. PubMed ID: 12646750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.
    Capitano B; Mattoes HM; Shore E; O'Brien A; Braman S; Sutherland C; Nicolau DP
    Chest; 2004 Mar; 125(3):965-73. PubMed ID: 15006955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.